1. Home
  2. JVA vs LGVN Comparison

JVA vs LGVN Comparison

Compare JVA & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

SELL

Current Price

$4.63

Market Cap

26.4M

ML Signal

SELL

Logo Longeveron Inc.

LGVN

Longeveron Inc.

SELL

Current Price

$2.45

Market Cap

21.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
JVA
LGVN
Founded
1971
2014
Country
United States
United States
Employees
92
N/A
Industry
Packaged Foods
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.4M
21.4M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
JVA
LGVN
Price
$4.63
$2.45
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $61.25
AVG Volume (30 Days)
76.6K
★ 145.6K
Earning Date
09-11-2026
11-03-2026
Dividend Yield
★ 1.73%
N/A
EPS Growth
N/A
★ 50.76
EPS
★ 0.68
N/A
Revenue
★ $90,655,294.00
$709,000.00
Revenue This Year
N/A
$46.15
Revenue Next Year
N/A
$396.46
P/E Ratio
$6.81
★ N/A
Revenue Growth
★ 17.54
N/A
52 Week Low
$2.93
$0.48
52 Week High
$5.03
$7.60

Technical Indicators

Market Signals
Indicator
JVA
LGVN
Relative Strength Index (RSI) 67.92 39.08
Support Level $4.15 $2.30
Resistance Level $4.59 $7.30
Average True Range (ATR) 0.18 0.21
MACD 0.05 -0.10
Stochastic Oscillator 79.16 17.69

Price Performance

Historical Comparison
JVA
LGVN

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: